L’Oreal Buys Back Shares From Nestle, Sells Galderma Stake
This article was originally published in The Rose Sheet
To finance a deal to purchase more than €6 billion of its own shares back from Nestle SA, L’Oreal SA has given up its half of skin-care company Galderma.
You may also be interested in...
The Estee Lauder Companies has its eyes peeled for potential acquisitions on the order of its MAC buy in the 1990s, making it one of a number of cosmetics firms with cash in hand and a view toward expansion. Kline & Company notes that the M&A market is heating up as the global economy improves and companies look to position themselves better in emerging markets and new product categories.
Swiss food and beverage company Nestle SA is growing its stake in skin care, particularly in North America, with its pending $1.4 billion acquisition of five aesthetic dermatology brands from Valeant Pharmaceuticals International Inc., which would be folded into the firm’s Nestle Skin Care Health division. Subject to regulatory approval, the deal demonstrates the firm’s new commitment to health and wellness, says analyst.
Sanofi SA has the cash to buy back about $12 billion worth of shares in its company that are currently owned by French beauty firm L’Oreal, if those shares were up for sale, Sanofi CEO Viehbacher says during Sept. 13 conference. L’Oreal CEO Agon suggested in recent earnings call that his firm could seek cash for future deals through the sale of its 9% stake in Sanofi.